Breaking News

Corgenix, EDP Biotech In Diagnostic Test Pact

July 12, 2013

To manufacture and supply ColoMarker test

Corgenix Medical Corp., a developer and marketer of diagnostic test kits, has entered into a contract manufacturing agreement with EDP Biotech to manufacture and supply the ColoMarker diagnostic test, a blood test developed to detect the early stages of colon cancer. Corgenix recently expanded its contract services business unit.
 
“We are pleased to enter into this mutually beneficial relationship with EDP,” said Douglass Simpson, president and chief executive officer of Corgenix. “This reflects our strategic focus on the Contract Services portion of our business for diagnostic products, and it meets the increasing demand overall for contract services in the medical device and biotechnology industries.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision